Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer
出版年份 2014 全文链接
标题
Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer
作者
关键词
-
出版物
ANNALS OF ONCOLOGY
Volume 25, Issue 3, Pages 657-662
出版商
Oxford University Press (OUP)
发表日期
2014-01-24
DOI
10.1093/annonc/mdt581
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
- (2013) Graeme J.K. Guthrie et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunomonitoring and prognostic relevance of neutrophils in clinical trials
- (2013) Frede Donskov SEMINARS IN CANCER BIOLOGY
- Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy
- (2012) Youngjoo Lee et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study
- (2012) David Olmos et al. LANCET ONCOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pretreatment Neutrophil-to-Lymphocyte Ratio in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram
- (2012) D. Keizman et al. ONCOLOGIST
- Protumor and antitumor functions of neutrophil granulocytes
- (2012) Sven Brandau et al. Seminars in Immunopathology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer
- (2010) Kim N. Chi et al. JOURNAL OF CLINICAL ONCOLOGY
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
- (2008) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started